Related Experiment Video
Updated: Apr 7, 2026

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
[The return of germline gene therapy]
1UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS, Espace éthique méditerranéen, hospital d'adultes la Timone, 264, rue Saint-Pierre, 13385 Marseille Cedex 05, France - CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 09, France.
The CRISPR-Cas9 gene editing tool rapidly advances animal model creation and gene therapy. However, it also presents significant ethical challenges regarding human germline modification, demanding immediate attention.
Area of Science:
- Genomics
- Molecular Biology
- Biotechnology
Context:
- CRISPR-Cas9 is a revolutionary genome editing technology.
- It offers unprecedented power and flexibility in genetic manipulation.
Purpose:
- To discuss the implications of CRISPR-Cas9 technology.
- To highlight its dual role in advancing research and raising ethical concerns.
Summary:
- CRISPR-Cas9 significantly accelerates the development of animal models for research.
- It also enhances the potential for somatic gene therapy applications.
Impact:
- Raises profound ethical questions regarding human germline modification.
- Necessitates urgent societal and scientific discussion on therapeutic aims versus enhancement.
- The ethical considerations are no longer theoretical but require immediate practical engagement.
More Related Videos
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
09:37Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
Published on: March 5, 2017
Related Concept Videos
Gene Therapy
Gene Therapy
What is Genetic Engineering?
In-vitro Mutagenesis
CRISPR